How long has xarelto been around?

See the DrugPatentWatch profile for xarelto

When did Xarelto (rivaroxaban) first get approved?

Xarelto is the brand name for rivaroxaban. In the U.S., rivaroxaban was first approved by the FDA in 2011. That means Xarelto has been on the market since 2011.

How long does that make it “around” today?

Counting from the 2011 FDA approval, Xarelto has been available for about 13–15 years depending on what month in 2011 the approval occurred relative to today.

What does “around” mean—approval vs. launch vs. clinical use?

People often mean different milestones:
- Regulatory approval: when it was authorized for prescribing (2011 in the U.S.).
- Market launch: when it became widely available (typically shortly after approval).
- Clinical adoption: when it became common for the specific conditions it’s used for (varies by indication and patient population).

Which indications made it visible first?

Xarelto’s early real-world uptake is commonly tied to major areas it’s approved for, such as stroke prevention in atrial fibrillation and treatment/prevention of blood clots (deep vein thrombosis and pulmonary embolism). The exact timing of each indication’s approval can differ, but the product itself dates back to the 2011 approval.

Sources:
1. https://www.drugs.com/xarelto.html